GB8601204D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB8601204D0
GB8601204D0 GB868601204A GB8601204A GB8601204D0 GB 8601204 D0 GB8601204 D0 GB 8601204D0 GB 868601204 A GB868601204 A GB 868601204A GB 8601204 A GB8601204 A GB 8601204A GB 8601204 D0 GB8601204 D0 GB 8601204D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
mixt
compsn
pref
xanthan gum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB868601204A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB868601204A priority Critical patent/GB8601204D0/en
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of GB8601204D0 publication Critical patent/GB8601204D0/en
Priority to IE342086A priority patent/IE59333B1/en
Priority to DE8787300035T priority patent/DE3779933T2/de
Priority to ES87300035T priority patent/ES2042541T4/es
Priority to AT87300035T priority patent/ATE77548T1/de
Priority to EP87300035A priority patent/EP0234670B1/en
Priority to IN9/MAS/87A priority patent/IN164250B/en
Priority to ZA87173A priority patent/ZA87173B/xx
Priority to NZ218907A priority patent/NZ218907A/xx
Priority to DK198700148A priority patent/DK175215B1/da
Priority to MYPI87000032A priority patent/MY100721A/en
Priority to FI870155A priority patent/FI93608C/fi
Priority to MX494987A priority patent/MX4949A/es
Priority to CA000527498A priority patent/CA1313133C/en
Priority to AU67625/87A priority patent/AU608208B2/en
Priority to NO870181A priority patent/NO173317C/no
Priority to PT84133A priority patent/PT84133B/pt
Priority to IL81281A priority patent/IL81281A/xx
Priority to PH34733A priority patent/PH26408A/en
Priority to JP62006312A priority patent/JPH0669965B2/ja
Priority to KR1019870000334A priority patent/KR940011242B1/ko
Priority to US07/687,090 priority patent/US5415871A/en
Priority to AU79462/91A priority patent/AU628754B2/en
Priority to GR920402118T priority patent/GR3005796T3/el
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GB868601204A 1986-01-18 1986-01-18 Therapeutic agents Pending GB8601204D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB868601204A GB8601204D0 (en) 1986-01-18 1986-01-18 Therapeutic agents
IE342086A IE59333B1 (en) 1986-01-18 1986-12-31 Therapeutic agents
EP87300035A EP0234670B1 (en) 1986-01-18 1987-01-06 Sustained-release pharmaceutical formulation containing xanthan gum
AT87300035T ATE77548T1 (de) 1986-01-18 1987-01-06 Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.
ES87300035T ES2042541T4 (es) 1986-01-18 1987-01-06 Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
DE8787300035T DE3779933T2 (de) 1986-01-18 1987-01-06 Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.
IN9/MAS/87A IN164250B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-01-18 1987-01-07
ZA87173A ZA87173B (en) 1986-01-18 1987-01-12 Therapeutic agents
NZ218907A NZ218907A (en) 1986-01-18 1987-01-13 Sustained release pill containing xanthan gum
DK198700148A DK175215B1 (da) 1986-01-18 1987-01-13 Fast farmaceutisk præparat med langvarig afgivelse af det aktive stof samt fremgangsmåde til fremstilling deraf
MYPI87000032A MY100721A (en) 1986-01-18 1987-01-14 Therapeutic agent.
FI870155A FI93608C (fi) 1986-01-18 1987-01-15 Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi
MX494987A MX4949A (es) 1986-01-18 1987-01-15 Una formulacion farmaceutica solida de liberacion sostenida y procedimiento para su preparacion.
PH34733A PH26408A (en) 1986-01-18 1987-01-16 Sustained release isuprofen composition
JP62006312A JPH0669965B2 (ja) 1986-01-18 1987-01-16 固体持続放出医薬製剤
AU67625/87A AU608208B2 (en) 1986-01-18 1987-01-16 Therapeutic agents
NO870181A NO173317C (no) 1986-01-18 1987-01-16 Fremgangsm}te for fremstilling av et fast farmas!ytisk preparat med forsinket frigj!ring
PT84133A PT84133B (pt) 1986-01-18 1987-01-16 Processo de preparacao de uma formulacao farmaceutica solida de libertacao controlada a base de goma de xantano
IL81281A IL81281A (en) 1986-01-18 1987-01-16 Sustained-release solid pharmaceuticals containing xanthan gum as a carrier
CA000527498A CA1313133C (en) 1986-01-18 1987-01-16 Therapeutic agents
KR1019870000334A KR940011242B1 (ko) 1986-01-18 1987-01-17 서방성 약제학적 제제의 제조방법
US07/687,090 US5415871A (en) 1986-01-18 1991-04-19 Therapeutic agents
AU79462/91A AU628754B2 (en) 1986-01-18 1991-06-28 Therapeutic agents
GR920402118T GR3005796T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-01-18 1992-09-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868601204A GB8601204D0 (en) 1986-01-18 1986-01-18 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB8601204D0 true GB8601204D0 (en) 1986-02-19

Family

ID=10591589

Family Applications (1)

Application Number Title Priority Date Filing Date
GB868601204A Pending GB8601204D0 (en) 1986-01-18 1986-01-18 Therapeutic agents

Country Status (23)

Country Link
US (1) US5415871A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0234670B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0669965B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR940011242B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE77548T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU608208B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1313133C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3779933T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK175215B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2042541T4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI93608C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB8601204D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3005796T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE59333B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL81281A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN164250B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX4949A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY100721A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO173317C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ218907A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH26408A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT84133B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA87173B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
IT1250483B (it) * 1990-08-30 1995-04-07 Eurand Int Sistema di ritardo a matrice multipla
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
EP0676967A4 (en) * 1992-12-30 1996-10-02 Fmc Corp RELEASED, EXTENDED, EASY TO PRODUCE EXCIPIENT, BASED ON KONJAC GLUCOMANNANE.
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5662933A (en) 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5464067A (en) * 1994-01-11 1995-11-07 Dulak; Joseph O. Golf marker cleaner and grass remover
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
FR2729857B1 (fr) 1995-01-27 1997-04-04 Rhone Poulenc Chimie Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
WO1997026865A1 (en) * 1996-01-29 1997-07-31 Edward Mendell Co., Inc. Sustained release excipient
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
IL123505A (en) 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
IN186245B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20030153623A1 (en) * 1998-07-22 2003-08-14 Yamanouchi Pharmaceutical Co., Ltd. Solid preparation containing sparingly soluble NSAIDs
GB9816723D0 (en) * 1998-08-01 1998-09-30 Boots Co Plc Therapeutic agents
AU772891B2 (en) 1998-12-11 2004-05-13 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
IL143375A0 (en) 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
US7235258B1 (en) * 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
WO2001078721A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
MY136634A (en) * 2000-08-22 2008-11-28 Encoate Holdings Ltd A thermo-stable bio-matrix
US20040022860A1 (en) * 2000-08-22 2004-02-05 Johson Von Walter Release composition and method of preparation
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001227030A1 (en) * 2000-11-22 2002-06-03 Lupin Laboratories Limited Pharmaceutical composition for controlled release of an active ingredient
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
CA2452874A1 (en) * 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8329216B2 (en) * 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
DE60117712T2 (de) * 2001-11-19 2006-11-16 Lupin Ltd., Mumbai Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam-antibiotikums
PL374350A1 (en) * 2002-03-22 2005-10-17 Cilag Ag Sustained release formulation of tramadol
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
MY148475A (en) * 2002-12-13 2013-04-30 Cilag Ag Controlled release preparations comprising tramadol and topiramate
WO2004054550A1 (en) * 2002-12-16 2004-07-01 Ranbaxy Laboratories Limited An extended release pharmaceutical composition of phenytoin sodium
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
EP2112920B1 (en) * 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
ATE390122T1 (de) * 2003-09-01 2008-04-15 Jpm The Jordanian Pharmaceutic Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
DE602005020462D1 (de) 2004-08-25 2010-05-20 Essentialis Inc Pharmazeutische formulierungen von kalium-atp-kanalöffnern und deren verwendungen
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
WO2006046954A1 (en) * 2004-10-26 2006-05-04 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
ES2403069T3 (es) * 2005-02-22 2013-05-13 Sun Pharma Advanced Research Company Ltd Composición oral de liberación controlada que contiene levetiracetam
US9757384B2 (en) 2005-04-06 2017-09-12 Essentialis, Inc. Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
NZ564789A (en) * 2005-07-22 2010-07-30 Myriad Genetics Inc High drug load formulations and dosage forms
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
RU2403013C2 (ru) * 2005-12-16 2010-11-10 Ханми Фарм. Ко., Лтд. Твердая дисперсия, содержащая активный ингредиент с низкой температурой плавления, и содержащая ее таблетка для перорального введения
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN101868239B (zh) 2006-01-05 2015-06-10 伊森舍丽斯有限公司 钾atp通道开放剂的盐及其用途
US8309104B2 (en) * 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
JP5457830B2 (ja) * 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US20090124650A1 (en) * 2007-06-21 2009-05-14 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
US20080318994A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
US20080318993A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
US20090062264A1 (en) * 2007-07-02 2009-03-05 Cowen Neil M Salts of potassium atp channel openers and uses thereof
DE102007032662A1 (de) * 2007-07-13 2009-01-22 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen enthaltend ein oder mehrere Apiogalacturonane oder einen oder mehrere Apiogalacturonane enthaltenden Extrakt aus Zostera marina und einen zusätzlichen Gehalt an einem oder mehreren Hydrokolloiden
EP2540294B1 (en) * 2010-02-22 2016-08-03 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
EP2793853B1 (en) * 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
WO2013100881A2 (en) 2011-12-27 2013-07-04 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined pharmaceutical formulation containing diacerein
WO2013130411A1 (en) 2012-02-27 2013-09-06 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
WO2014007778A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi COMBINED IMMEDIATE RELEASE FORMULATIONS OF NSAIDs
WO2014007777A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined capsule formulations of nsaids
MY187610A (en) 2014-11-14 2021-10-04 Essentialis Inc Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome
CN108904451A (zh) * 2018-07-27 2018-11-30 广州柏赛罗药业有限公司 缓释制剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR901111A (fr) * 1943-08-31 1945-07-18 Perfectionnement aux dispositifs de réglage de terrage des charruesbascules
US3065143A (en) 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
FR2138492A1 (en) * 1971-05-27 1973-01-05 Cerm Cent Europ Rech Mauvernay Basic aluminium salts of gum xanthane - pharmaceutical gelling agents
DE2130545A1 (de) 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
JPS5470420A (en) * 1977-11-10 1979-06-06 Sanei Kagaku Kogyo Kk Binder for medical tablet
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
IN151913B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1980-01-11 1983-09-03 Boots Co Ltd
CA1207231A (en) * 1982-08-24 1986-07-08 Hans W. Zulliger Medicated suppository
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
JPS60219238A (ja) * 1984-04-14 1985-11-01 Hayashibara Biochem Lab Inc 徐崩性プルラン含有成形物とその製法
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
BE901111A (fr) * 1984-11-22 1985-03-15 Benfar Representee Par Vanderl Composition pharmaceutiques a liberation prolongee, leur procede de preparation et leur utilisation.
EP0182772A3 (fr) * 1984-11-22 1987-04-01 Benfar Compositions pharmaceutiques à libération prolongée, leur procédé de préparation et leur utilisation
JPS61130239A (ja) * 1984-11-30 1986-06-18 Dai Ichi Seiyaku Co Ltd 複合体
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient

Also Published As

Publication number Publication date
NO173317B (no) 1993-08-23
IL81281A (en) 1990-11-29
ATE77548T1 (de) 1992-07-15
EP0234670A2 (en) 1987-09-02
DK14887A (da) 1987-07-19
FI870155L (fi) 1987-07-19
NO870181D0 (no) 1987-01-16
KR940011242B1 (ko) 1994-12-03
FI870155A0 (fi) 1987-01-15
FI93608C (fi) 1995-05-10
AU6762587A (en) 1987-07-23
DE3779933T2 (de) 1992-12-10
ZA87173B (en) 1987-08-26
DK14887D0 (da) 1987-01-13
PT84133A (en) 1987-02-01
PH26408A (en) 1992-07-02
IL81281A0 (en) 1987-08-31
AU628754B2 (en) 1992-09-17
NO870181L (no) 1987-07-20
IE863420L (en) 1987-07-18
IE59333B1 (en) 1994-02-09
FI93608B (fi) 1995-01-31
US5415871A (en) 1995-05-16
GR3005796T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-07
KR870006896A (ko) 1987-08-13
EP0234670A3 (en) 1988-01-13
MY100721A (en) 1991-01-31
JPH0669965B2 (ja) 1994-09-07
CA1313133C (en) 1993-01-26
DK175215B1 (da) 2004-07-12
AU608208B2 (en) 1991-03-28
MX4949A (es) 1993-12-01
AU7946291A (en) 1991-09-12
IN164250B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-02-04
ES2042541T4 (es) 1996-07-16
ES2042541T3 (es) 1993-12-16
DE3779933D1 (de) 1992-07-30
NZ218907A (en) 1989-05-29
PT84133B (pt) 1989-05-31
EP0234670B1 (en) 1992-06-24
JPS62181227A (ja) 1987-08-08
NO173317C (no) 1993-12-01

Similar Documents

Publication Publication Date Title
GB8601204D0 (en) Therapeutic agents
IL89602A0 (en) Compositions containing bioactive agents and methods for the preparation thereof
CA2063819A1 (en) Chewing gum composition with accelerated, controlled release of active agents
ES8607009A1 (es) Un metodo para preparar una forma de dosificacion unitaria solida, terapeuticamente activa
AU5363094A (en) Concentrated bioavailable calcium source
MY101784A (en) Novel pharmacological compounds
GR1002907B (el) Επικαλυμμενο δισκιο μηλεινικης τριμεβουτινης
IL78061A (en) Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane
CA2052901A1 (en) Pharmacologically enhanced formulations
GR3002835T3 (en) Pharmaceutical compositions containing pentamidine
NZ514322A (en) Particle based vaccine composition
CA2103725A1 (en) Composition for use in transdermal administration
PH27567A (en) Topical compositions
GR3002765T3 (en) New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient
EP0275526A3 (en) Composition for administration through a body cavity
CA2259270A1 (en) Pharmaceutical preparation containing nimesulide for oral administration
JPS57142913A (en) Donor of physiologically active substance
NO894083D0 (no) Framsoeytiske blandinger for behandling av adrenoleukodystrophy.
GR3003678T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES8802560A1 (es) Un metodo para la preparacion de derivados estables efervescentes de acido acetilsalicilico con propiedades antihistaminicas.
MY106605A (en) Compositions for the treatment of leishmaniasis
AU103222S (en) Trestle